Combinations of renal vasodilators and .alpha..sub.1 -adrenergic

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3702

Patent

active

047496860

ABSTRACT:
This invention relates to combinations and methods for the treatment of renal disease, cardiovascular disease and hypertension. More particularly, the invention relates to combinations of renal vasodilators and .alpha..sub.1 -adrenergic or ganglionic blocking agents. According to a preferred embodiment, atriopeptins having renal vasodilator activity are used in combination with .alpha..sub.1 -adrenergic blocking agents for treating renal disease, cardiovascular disease and hypertension. The blocking agent promotes sustained renal vasodilation, thereby enhancing renal blood flow and kidney function.

REFERENCES:
Chem. Abstr. vol. 71, (1969) 69158.
Chem. Abstr. vol. 103 (1985) 64636.
Chem. Abstr. vol. 106 (1987) 60959.
Chem. Abstr. vol. 105 (1986) 209252.
Chem. Abstr. vol. 104, (1986) 82397.
Chem. Abstr. vol. 103 (1985) 87727.
Chem. Abstr. vol. 99, (1983) 191046.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Combinations of renal vasodilators and .alpha..sub.1 -adrenergic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combinations of renal vasodilators and .alpha..sub.1 -adrenergic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of renal vasodilators and .alpha..sub.1 -adrenergic will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-844912

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.